Showing results (391-400 of 406) with videos related to
Sort By:
Pageof 41
Gynecologic Oncology|February 3, 2019
Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional studyShin Nishio, Yoshiki Mikami, Hideki Tokunaga, et al.Journal of Molecular and Cellular Cardiology|May 31, 2019
Sirt1 counteracts decrease in membrane phospholipid unsaturation and diastolic dysfunction during saturated fatty acid overloadTsunehisa Yamamoto, Jin Endo, Masaharu Kataoka, et al.Nature Communications|May 31, 2022
Omega-3 fatty acid epoxides produced by PAF-AH2 in mast cells regulate pulmonary vascular remodelingHidenori Moriyama, Jin Endo, Masaharu Kataoka, et al.Biomed Research International|September 5, 2015
Putative Epimutagens in Maternal Peripheral and Cord Blood Samples Identified Using Human Induced Pluripotent Stem CellsYoshikazu Arai, Koji Hayakawa, Daisuke Arai, et al.Anticancer Research|May 6, 2020
Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse ModelJun Yamamoto, Takuya Murata, Norihiko Sugisawa, et al.Gynecologic Oncology|November 9, 2017
Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective studyMitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda, et al.Gynecologic Oncology|October 23, 2019
A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypesMitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda, et al.Anticancer Research|May 6, 2020
A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to OlaparibJun Yamamoto, Takuya Murata, Yoshihiko Tashiro, et al.Journal of Gynecologic Oncology|May 26, 2017
Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator ConferenceJi Yon Agnes Jang, Nozomu Yanaihara, Eric Pujade-Lauraine, et al.Cell Stem Cell|December 26, 2017
Direct In Vivo Reprogramming with Sendai Virus Vectors Improves Cardiac Function after Myocardial InfarctionKazutaka Miyamoto, Mizuha Akiyama, Fumiya Tamura, et al.Pageof 41